title: Quantification of remifentanil and propofol in human plasma: a LC-MS/MS assay validated according to the EMA guideline.
abstract: BACKGROUND
  Remifentanil and propofol are often used in combination for general anesthesia. We developed a method using LC-MS for their simultaneous measurement in human plasma. Methodology & results: After addition of remifentanil-(13)C6 and propofol-d18 (IS), 500 µl of plasma were extracted with ethylacetate/hexane. Analysis conditions included gradient elution (water/acetonitrile), electrospray ionization and detection with a triple quadripole mass spectrometer. Remifentanil and propofol were ionized in the positive and negative mode, respectively. The method was validated according to the European Medicines Agency guideline for the validation of bioanalytical methods, then successfully applied to clinical samples from three patients who had undergone liver transplantation.
  
  
  CONCLUSIONS
  This method is suitable for the simultaneous quantification of remifentanil and propofol in clinical studies.
authors.affiliation: Plateforme de spectrométrie de masse MasSpecLab, UFR des Sciences de la Santé Simone Veil, Université Versailles Saint Quentin, 2 avenue de la source de la Bièvre, 78180 Montigny le Bretonneux, France.|Laboratoire de Pharmacologie - Toxicologie, Hôpital Raymond Poincaré, AP-HP, Garches, France.
authors.forename: Jean Claude
authors.initials: JC
authors.lastname: Alvarez
authors.affiliation: Laboratoire de Pharmacologie - Toxicologie, Hôpital Raymond Poincaré, AP-HP, Garches, France.
authors.forename: Emuri
authors.initials: E
authors.lastname: Abe
authors.affiliation: Laboratoire de Pharmacologie - Toxicologie, Hôpital Raymond Poincaré, AP-HP, Garches, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Etting
authors.affiliation: Service d'Anesthésie - Réanimation, Hôpital Foch, Suresnes, France.
authors.forename: Morgan
authors.initials: M
authors.lastname: Le Guen
authors.affiliation: Laboratoire de Pharmacologie UPRES EA220, Hôpital Foch, Suresnes, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Devillier
authors.affiliation: Plateforme de spectrométrie de masse MasSpecLab, UFR des Sciences de la Santé Simone Veil, Université Versailles Saint Quentin, 2 avenue de la source de la Bièvre, 78180 Montigny le Bretonneux, France.|Délégation à la Recherche Clinique et à l'Innovation, Hôpital Foch, Suresnes, France.
authors.forename: Stanislas
authors.initials: S
authors.lastname: Grassin-Delyle
mesh_terms: D002853:Chromatography, Liquid / Q000379:methods; D017277:Drug Approval; D005060:Europe; D006801:Humans; D006993:Hypnotics and Sedatives / Q000097:blood*; D008958:Models, Molecular; D010880:Piperidines / Q000097:blood*; D015742:Propofol / Q000097:blood*; D000077208:Remifentanil; D053719:Tandem Mass Spectrometry / Q000379:methods
chemical_list: D006993:Hypnotics and Sedatives; D010880:Piperidines; D000077208:Remifentanil; D015742:Propofol